HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 5, 2001, Pages 401-409

  Franzke, A ^a   Buer, J ^a   Probst Kepper, M ^a   Lindig, C ^a   Framzle, M ^a   Schrader, A J ^a   Ganser, A ^a   Atzpodien, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cytokine; HLA; Interleukin 2; Renal cell cancer; Tumor immunology

Indexed keywords

CYTOKINE; HLA ANTIGEN; INTERLEUKIN 2; RECOMBINANT ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER IMMUNOLOGY; CANCER REGRESSION; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION FUNCTION; ETHNOLOGY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SEROTYPING;

EID: 0035217510     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497801753354302     Document Type: Article

References (28)

1. Home therapy with recombinant IL-2 and recombinant interferon alpha 2B in advanced human malignancies
2. Correlation between clinical response to interleukin-2 and HLA phenotypes in patients with metastatic renal cell cancer
3. Population analysis on the basis of deduced haplotypes from random families
4. Cellular immune response to human renal cell carcinomas: Definition of a common antigen recognized by HLA.A2-restricted cytotoxic T-lymphocyte clones
5. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes
6. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma
7. Prolonged survival in broncogenic carcinoma associated with HLA-A antigens W19 and A5: A preliminary report
8. HLA-antigens and survival in Hodgkin's disease
9. Autoimmunity resulting from cytokine-treatment predicts long-term survival in renal cell carcinoma patients
10. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal cell carcinoma
11. Structure of the complex between human T-cell receptor, viral peptide and HLA.A2
12. Peptide binding specificity of HLA.DR4 molecules. Correlation with rheumatoid arthritis association
13. Common West African HLA antigens are associated with protection from severe malaria
14. HLA antigens in renal cell carcinoma
15. Genetic basis of susceptibility to viral leukaemogenesis
16. Interleukin-2 based home therapy of metastatic renal cell cancer: Risk and benefits in 215 consecutive single institute patients
17. HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy
18. Association of HLA phenotype with response to active specific immunotherapy of melanoma
19. HLA.A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer
20. HLA linked resistance factors and survival in acute myelogenous leukemia
21. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
22. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes
23. HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2
24. HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)
25. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: HLA.A2-restricted recognition of autologous and allogeneic tumor lines
26. HLA associated diseases
27. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance
28. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system